HMGCR and cardiovascular disorder: Although statins, which are inhibitors of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase, the rate-limiting enzyme for cholesterol synthesis), are best at reducing serum cholesterol in order to prevent cardiovascular diseases, they present a modestly increased risk for the onset of new diabetes cases16–19.